BRITTANY WEST: Open Payments
NPI 1639537020 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,674 in 72 payments from 26 companies in 2025. Trend: 2023 $1,343 · 2024 $1,957 · 2025 $1,674
Food & beverage: $1,674
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $316 |
| Eisai Inc. | 8 | $196 |
| AstraZeneca Pharmaceuticals LP | 5 | $141 |
| GlaxoSmithKline, LLC. | 9 | $139 |
| SpringWorks Therapeutics, Inc. | 1 | $120 |
| PFIZER INC. | 5 | $85 |
| Astellas Pharma US Inc | 3 | $78 |
| ABBVIE INC. | 2 | $56 |
| Janssen Biotech, Inc. | 2 | $51 |
| Amgen Inc. | 3 | $49 |
Products named: Leqembi, OGSIVEO, TRELEGY ELLIPTA, AIRSUPRA, Veozah, Wegovy, ELIQUIS, Rybelsus.
Industry payments across AZ — which companies pay providers there.
